| Literature DB >> 11963990 |
Hiroyuki Naito1, Satoru Ohsuki, Masamichi Sugimori, Ryo Atsumi, Megumi Minami, Yoshihide Nakamura, Mineko Ishii, Kenji Hirotani, Eiji Kumazawa, Akio Ejima.
Abstract
A series of novel 3-substituted-1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-1-trans-propenes in order to improve the in vitro and in vivo activity of our prototype 3-[4-(3-chlorophenyl)-1-piperazinyl]-1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-1-trans-propene (2) were synthesized and evaluated by assays of growth inhibition against several tumor cell lines in vitro and antitumor activity against some tumor models when dosed both intraperitoneally and orally in vivo. Compounds 7a and 7e, the 3,5-difluorophenyl and 3,5-dichlorophenyl analogues of 2, respectively, showed significantly more potent cytotoxicity than 2 in vitro and potent antitumor activities without causing decrease of body temperature related to side effects.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11963990 DOI: 10.1248/cpb.50.453
Source DB: PubMed Journal: Chem Pharm Bull (Tokyo) ISSN: 0009-2363 Impact factor: 1.645